Ipamorelin
Examine ipamorelin human hormone studies, the postoperative trial, animal findings and FDA safety concerns without overstating clinical benefits.
Read research profile ↗COMPOUND INDEX
Compound Index.
Understand the research.
Research questions, reported findings, and evidence limits.
78 matching profiles
Kisspeptin
Review kisspeptin-10 and kisspeptin-54 human research on hormones, IVF, sexual desire and anxiety, with clear safety and evidence limits.
Read research profile ↗KLOW
Understand what KPV intestinal research contributes to the KLOW rationale and why a four-ingredient listing does not establish added repair benefit.
Read research profile ↗KPV
Evaluate KPV intestinal-cell and mouse colitis studies, peptide transport and nanoparticle delivery, with clear distinctions from human treatment evidence.
Read research profile ↗L-Carnitine
Review L-Carnitine recovery research, the negative cancer-fatigue trial, deficiency care and limits of weight-loss and injectable-product claims.
Read research profile ↗Livagen
Review Livagen liver-explant and patient-derived cell studies, separating genomic measurements from clinical liver, cancer and cardiovascular claims.
Read research profile ↗LL-37
Read LL-37 wound-healing research in context: venous-ulcer and diabetic-foot trials, mixed outcomes, antimicrobial claims and FDA safety concerns.
Read research profile ↗Mazdutide
Compare Mazdutide GLORY-1, GLORY-2 and US phase 2 results, including weight changes, analysis methods and gastrointestinal tolerability.
Read research profile ↗Melanotan II
Examine Melanotan II tanning and erectile-response studies, serious safety reports, product identity and the limits of early human evidence.
Read research profile ↗MGF
Compare MGF osteoblast findings with negative muscle-cell replication research, distinguishing peptide identity, proliferation and functional tissue repair.
Read research profile ↗MOTS-C
Explore MOTS-c metabolic research, mouse performance findings, human exercise observations and FDA evidence gaps without overstating clinical benefits.
Read research profile ↗NAD+
Review the NAD+ infusion pilot, distinguish precursor research from direct NAD+ evidence, and examine FDA injectable-product safety concerns.
Read research profile ↗Neuroxelin
Understand Neuroxelin ingredient listings, modified-peptide distinctions and the evidence needed to support a finished cognitive-research blend.
Read research profile ↗Ovagen
Explore EDL and T-35 renal research, animal injury models and transport hypotheses while distinguishing the separate Ovagen FSH preparation.
Read research profile ↗Oxytocin
Examine oxytocin medical uses, intranasal autism trials, trust research, placebo responses and safety limits with primary-source evidence.
Read research profile ↗Pancragen
Examine Pancragen glucose-tolerance studies in aged rhesus monkeys, including a small glimepiride comparison and limits on human treatment claims.
Read research profile ↗PE-22-28
Examine PE-22-28 channel experiments and mouse findings without converting preclinical activity or analog results into proven human depression treatment.
Read research profile ↗PEG MGF
Assess PEG-MGF identity and half-life claims, related MGF findings, FDA safety concerns and the missing direct evidence for human recovery benefits.
Read research profile ↗